| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Yamins Laboratory for Surgical Research, Beth Israel Hospital, and Department of Surgery, Beth Israel Hospital and Harvard Medical School, Boston, Massachusetts 02215
Qualitative and quantitative studies on crude preparations of aspartate transcarbamylase from normal and neoplastic human colon were carried out. Whereas the activity of the enzyme was markedly higher in neoplastic tissue, no qualitative differences were observed between the enzymes from the two types of tissues. Negative feedback inhibition of human colon aspartate transcarbamylase could not be demonstrated.
1 Supported by Grants CA-02528 and CA-02972 and Contract PH 43-63-1154 from the National Cancer Institute, NIH, USPHS, Bethesda, Maryland.
Received 10/ 7/66. Accepted 4/18/67.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |